A Neesse1, H Griesmann, T M Gress, P Michl. 1. Department of Gastroenterology, Endocrinology and Metabolism, Philipps University Marburg, Baldinger Str., 35043 Marburg, Germany.
Abstract
BACKGROUND: Intercellular junctional complexes such as adherens junctions and tight junctions are critical regulators of cellular polarity, paracellular permeability and metabolic and structural integrity of cellular networks. Abundant expression analysis data have yielded insights into the complex pattern of differentially expressed cell-adhesion proteins in epithelial cancers and provide a useful platform for functional, preclinical and clinical evaluation of novel targets. SCOPE OF REVIEW: This review will focus on the role of claudin-4, an integral constituent of tight junctions, in the pathophysiology of epithelial malignancies with particular focus pancreatic cancer, and its potential applicability for prognostic, diagnostic and therapeutic approaches. MAJOR CONCLUSIONS: Claudin-4 expression is widely dysregulated in epithelial malignancies and in a number of premalignant precursor lesions. Although the functional implications are only starting to unravel, claudin-4 seems to play an important role in tumour cell invasion and metastasis, and its dual role as receptor of Clostridium perfringens enterotoxin (CPE) opens exciting avenues for molecular targeted approaches. GENERAL SIGNIFICANCE: Claudin-4 constitutes a promising molecular marker for prognosis, diagnosis and therapy of epithelial malignancies.
BACKGROUND: Intercellular junctional complexes such as adherens junctions and tight junctions are critical regulators of cellular polarity, paracellular permeability and metabolic and structural integrity of cellular networks. Abundant expression analysis data have yielded insights into the complex pattern of differentially expressed cell-adhesion proteins in epithelial cancers and provide a useful platform for functional, preclinical and clinical evaluation of novel targets. SCOPE OF REVIEW: This review will focus on the role of claudin-4, an integral constituent of tight junctions, in the pathophysiology of epithelial malignancies with particular focus pancreatic cancer, and its potential applicability for prognostic, diagnostic and therapeutic approaches. MAJOR CONCLUSIONS: Claudin-4 expression is widely dysregulated in epithelial malignancies and in a number of premalignant precursor lesions. Although the functional implications are only starting to unravel, claudin-4 seems to play an important role in tumour cell invasion and metastasis, and its dual role as receptor of Clostridium perfringens enterotoxin (CPE) opens exciting avenues for molecular targeted approaches. GENERAL SIGNIFICANCE: Claudin-4 constitutes a promising molecular marker for prognosis, diagnosis and therapy of epithelial malignancies.
Authors: Györgyi A Nelhűbel; Boróka Károly; Balázs Szabó; Gábor Lotz; András Kiss; József Tóvári; István Kenessey Journal: Pathol Oncol Res Date: 2013-07-12 Impact factor: 3.201
Authors: Ágnes Holczbauer; Benedek Gyöngyösi; Gábor Lotz; Attila Szijártó; Péter Kupcsulik; Zsuzsa Schaff; András Kiss Journal: J Histochem Cytochem Date: 2013-02-05 Impact factor: 2.479
Authors: Elizabeth Cristina Perez; Patricia Xander; Maria Fernanda Lucatelli Laurindo; Ronni Rômulo Novaes E Brito; Bruno Camolese Vivanco; Renato Arruda Mortara; Mario Mariano; José Daniel Lopes; Alexandre Castro Keller Journal: PLoS One Date: 2017-11-16 Impact factor: 3.240
Authors: Madeleine K D Scott; Maneesha Limaye; Steven Schaffert; Robert West; Michael G Ozawa; Pauline Chu; Viswam S Nair; Albert C Koong; Purvesh Khatri Journal: Pac Symp Biocomput Date: 2021
Authors: Albrecht Neesse; Sebastian Krug; Thomas M Gress; David A Tuveson; Patrick Michl Journal: Onco Targets Ther Date: 2013-12-18 Impact factor: 4.147